Lanjun Zhang

Erlotinib versus vinorelbine plus cisplatin as adjuvant therapy in Chinese patients with stage IIIA EGFR mutation-positive non-small-cell lung cancer (EVAN): a randomised, open-label, phase 2 trial

Dongsheng Yue, Shidong Xu, Qun Wang et al. · The Lancet Respiratory Medicine · 2018 · 293 citations

Medicine, Oncology, Pharmacology +13

Effect of acid treatment on the characteristics and structures of high-sulfur bituminous coal

Lanjun Zhang, Zenghua Li, Yongliang Yang et al. · Fuel · 2016 · 162 citations

Natural Sciences, Chemistry, Mining Engineering +12

The genomic landscape of Epstein-Barr virus-associated pulmonary lymphoepithelioma-like carcinoma

Shaodong Hong, Dongbing Liu, Wenfeng Fang et al. · Nature Communications · 2019 · 128 citations · Full text

Medicine, Genetics, Oncology +17

Over‐expression of AEG‐1 significantly associates with tumour aggressiveness and poor prognosis in human non‐small cell lung cancer

Libing Song, Wen Li, Huizhong Zhang et al. · The Journal of Pathology · 2009 · 109 citations

Medicine, Molecular Biology, Oncology +11

Identification and Validation of Lymphovascular Invasion as a Prognostic and Staging Factor in Node-Negative Esophageal Squamous Cell Carcinoma

Qingyuan Huang, Kongjia Luo, Chun Chen et al. · Journal of Thoracic Oncology · 2016 · 95 citations

Medicine, Oncology, Pathology +16